Medicament for increasing the testosterone level
Patent 5578588 Issued on November 26, 1996. Estimated Expiration Date: 
November 7, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 7, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3284303 Administration of steroid hormones Methods for treatment of male-pattern baldness Patent #: 5053403 InventorsAssigneeApplicationNo. 335729 filed on 11/07/1994US Classes:514/177, Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/182Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring systemExaminersPrimary: Jordan, KimberlyAttorney, Agent or FirmForeign Patent References
International ClassA61K 031/56Foreign Application Priority Data1992-05-06 DEAbstractThe invention concerns a drug for increasing the level of testosterone in the human body, the drug containing at least one testosterone precursor.Other References
| |
